메뉴 건너뛰기




Volumn 10, Issue 8, 2014, Pages 1661-1666

Just so stories: The random acts of anti-cancer nanomedicine performance

Author keywords

Cancer; Complement system; Enhanced permeability and retention; Nanomedicine; Spontaneous tumors; Systems immunology; Xenografts

Indexed keywords

CLINICAL RESEARCH; IMMUNOLOGY; MEDICAL NANOTECHNOLOGY; ONCOLOGY; TUMORS;

EID: 84908571917     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.04.011     Document Type: Article
Times cited : (73)

References (52)
  • 1
    • 14644396096 scopus 로고    scopus 로고
    • Nanomedicine: current status and future prospects
    • Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J 2005, 19:311-330.
    • (2005) FASEB J , vol.19 , pp. 311-330
    • Moghimi, S.M.1    Hunter, A.C.2    Murray, J.C.3
  • 2
    • 81855198887 scopus 로고    scopus 로고
    • Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective
    • Moghimi S.M., Hunter A.C., Andresen T.L. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu Rev Pharmacol Toxicol 2012, 52:381-503.
    • (2012) Annu Rev Pharmacol Toxicol , vol.52 , pp. 381-503
    • Moghimi, S.M.1    Hunter, A.C.2    Andresen, T.L.3
  • 3
    • 84861669644 scopus 로고    scopus 로고
    • Doxil(r)-The first FDA-approved nano-drug: lessons learned
    • Barenholz Y. Doxil(r)-The first FDA-approved nano-drug: lessons learned. J Control Rel 2012, 160:117-133.
    • (2012) J Control Rel , vol.160 , pp. 117-133
    • Barenholz, Y.1
  • 4
    • 81855218204 scopus 로고    scopus 로고
    • Reshaping the future of nanopharmaceuticals: ad iudicium
    • Moghimi S.M., Peer D., Langer R. Reshaping the future of nanopharmaceuticals: ad iudicium. ACS Nano 2011, 5:8353-8358.
    • (2011) ACS Nano , vol.5 , pp. 8353-8358
    • Moghimi, S.M.1    Peer, D.2    Langer, R.3
  • 6
    • 84870236985 scopus 로고    scopus 로고
    • Anticancer nanomedicine and tumor vascular permeability; where is the missing link?
    • Taurin S., Nehoff H., Greish K. Anticancer nanomedicine and tumor vascular permeability; where is the missing link?. J Control Rel 2012, 163:265-275.
    • (2012) J Control Rel , vol.163 , pp. 265-275
    • Taurin, S.1    Nehoff, H.2    Greish, K.3
  • 7
    • 78049452610 scopus 로고    scopus 로고
    • Delivering nanomedicine to solid tumors
    • Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010, 7:653-663.
    • (2010) Nat Rev Clin Oncol , vol.7 , pp. 653-663
    • Jain, R.K.1    Stylianopoulos, T.2
  • 8
    • 84884915152 scopus 로고    scopus 로고
    • Facing the truth about nanotechnology in drug delivery
    • Park K. Facing the truth about nanotechnology in drug delivery. ACS Nano 2013, 7:7332-7337.
    • (2013) ACS Nano , vol.7 , pp. 7332-7337
    • Park, K.1
  • 9
    • 84886310583 scopus 로고    scopus 로고
    • Strategies for advancing cancer nanomedicine
    • Chauhan V.P., Jain R.K. Strategies for advancing cancer nanomedicine. Nat Mat 2013, 12:958-962.
    • (2013) Nat Mat , vol.12 , pp. 958-962
    • Chauhan, V.P.1    Jain, R.K.2
  • 11
    • 0022858683 scopus 로고
    • A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
    • Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 36:6387-6392.
    • (1986) Cancer Res , vol.36 , pp. 6387-6392
    • Matsumura, Y.1    Maeda, H.2
  • 12
    • 0022495733 scopus 로고
    • Microvascular permeability of normal and neoplastic tissues
    • Gerlowski L.E., Jain R.K. Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986, 31:288-305.
    • (1986) Microvasc Res , vol.31 , pp. 288-305
    • Gerlowski, L.E.1    Jain, R.K.2
  • 14
    • 0035816177 scopus 로고    scopus 로고
    • Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function
    • Jain R.K. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J Control Rel 2001, 73:7-25.
    • (2001) J Control Rel , vol.73 , pp. 7-25
    • Jain, R.K.1
  • 16
    • 79551629547 scopus 로고    scopus 로고
    • Is human cell therapy research caught in a mousetrap?
    • Barrett A.J., Melenhorst J.J. Is human cell therapy research caught in a mousetrap?. Mol Ther 2011, 19:224-227.
    • (2011) Mol Ther , vol.19 , pp. 224-227
    • Barrett, A.J.1    Melenhorst, J.J.2
  • 17
    • 84860620155 scopus 로고    scopus 로고
    • Cancer stromal targeting (CAST) therapy
    • Matsumura Y. Cancer stromal targeting (CAST) therapy. Adv Drug Deliv Rev 2012, 64:710-719.
    • (2012) Adv Drug Deliv Rev , vol.64 , pp. 710-719
    • Matsumura, Y.1
  • 19
    • 0035127410 scopus 로고    scopus 로고
    • Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes
    • Harrington K.J., Mohammadtaghi S., Uster P.S., Glaa D., Peters A.M., Vile R.G., et al. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 2001, 7:233-253.
    • (2001) Clin Cancer Res , vol.7 , pp. 233-253
    • Harrington, K.J.1    Mohammadtaghi, S.2    Uster, P.S.3    Glaa, D.4    Peters, A.M.5    Vile, R.G.6
  • 20
    • 84896504632 scopus 로고    scopus 로고
    • Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles
    • Toy R., Peiris P.M., Ghaghada K.B., Karathanasis E. Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (Lond) 2013, 9:121-133.
    • (2013) Nanomedicine (Lond) , vol.9 , pp. 121-133
    • Toy, R.1    Peiris, P.M.2    Ghaghada, K.B.3    Karathanasis, E.4
  • 21
    • 0029379535 scopus 로고
    • Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents
    • Moghimi S.M. Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents. Adv Drug Deliv Rev 1995, 17:103-115.
    • (1995) Adv Drug Deliv Rev , vol.17 , pp. 103-115
    • Moghimi, S.M.1
  • 22
    • 38549112058 scopus 로고    scopus 로고
    • Translation of new cancer treatments from pet dogs to humans
    • Paoloni M., Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 2008, 8:137-156.
    • (2008) Nat Rev Cancer , vol.8 , pp. 137-156
    • Paoloni, M.1    Khanna, C.2
  • 23
    • 84255196931 scopus 로고    scopus 로고
    • Immune microenvironments in solid tumors: new targets for therapy
    • Shiao S.L., Ganesan P., Rugo H.S., Coussens L.M. Immune microenvironments in solid tumors: new targets for therapy. Genes Dev 2011, 25:2559-2572.
    • (2011) Genes Dev , vol.25 , pp. 2559-2572
    • Shiao, S.L.1    Ganesan, P.2    Rugo, H.S.3    Coussens, L.M.4
  • 24
    • 84866784798 scopus 로고    scopus 로고
    • Leukocyte complexity in breast cancer predicts overall survival and functionally regulates response to chemotherapy
    • De Nardo D.G., Brennan D., Rexhapaj E., Ruffel B., Shiao S., Gallagher W.M., et al. Leukocyte complexity in breast cancer predicts overall survival and functionally regulates response to chemotherapy. Cancer Discov 2011, 1:54-67.
    • (2011) Cancer Discov , vol.1 , pp. 54-67
    • De Nardo, D.G.1    Brennan, D.2    Rexhapaj, E.3    Ruffel, B.4    Shiao, S.5    Gallagher, W.M.6
  • 25
    • 78651461701 scopus 로고    scopus 로고
    • HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through down- regulation of PlGF
    • Rolney C., Mazzone M., Tugues S., Laoui D., Johansson I., Coulon C., et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through down- regulation of PlGF. Cancer Cell 2011, 19:31-44.
    • (2011) Cancer Cell , vol.19 , pp. 31-44
    • Rolney, C.1    Mazzone, M.2    Tugues, S.3    Laoui, D.4    Johansson, I.5    Coulon, C.6
  • 26
    • 27144466756 scopus 로고    scopus 로고
    • Only a specific subset of human peripheral blood monocytes has endothelial-like functional capacity
    • Elsheikh E., Uzunel M., He Z., Holgersson J., Nowak G., Sumitran- Holgersson S. Only a specific subset of human peripheral blood monocytes has endothelial-like functional capacity. Blood 2005, 106:2347-2355.
    • (2005) Blood , vol.106 , pp. 2347-2355
    • Elsheikh, E.1    Uzunel, M.2    He, Z.3    Holgersson, J.4    Nowak, G.5    Sumitran-Holgersson, S.6
  • 27
    • 34249979533 scopus 로고    scopus 로고
    • Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer
    • Venneri M.A., Palma M.D., Ponzoni M., Pucci F., Scielzo C., Zonari E., et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 2007, 109:5276-5285.
    • (2007) Blood , vol.109 , pp. 5276-5285
    • Venneri, M.A.1    Palma, M.D.2    Ponzoni, M.3    Pucci, F.4    Scielzo, C.5    Zonari, E.6
  • 28
    • 4644345036 scopus 로고    scopus 로고
    • Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of VEGF-A
    • Conejo-Garcia J.R., Benencia F., Courreges M.C., Kang E., Mohamed-Hadley A., Buckanovich R.J., et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of VEGF-A. Nat Med 2004, 10:950-958.
    • (2004) Nat Med , vol.10 , pp. 950-958
    • Conejo-Garcia, J.R.1    Benencia, F.2    Courreges, M.C.3    Kang, E.4    Mohamed-Hadley, A.5    Buckanovich, R.J.6
  • 29
    • 4644237613 scopus 로고    scopus 로고
    • Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    • Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004, 10:942-949.
    • (2004) Nat Med , vol.10 , pp. 942-949
    • Curiel, T.J.1    Coukos, G.2    Zou, L.3    Alvarez, X.4    Cheng, P.5    Mottram, P.6
  • 32
    • 64149086047 scopus 로고    scopus 로고
    • Complement-mediated tumour growth: implications for cancer nanotechnology and nanomedicines
    • Moghimi S.M., Andresen T.L. Complement-mediated tumour growth: implications for cancer nanotechnology and nanomedicines. Mol Immunol 2009, 36:1571-1572.
    • (2009) Mol Immunol , vol.36 , pp. 1571-1572
    • Moghimi, S.M.1    Andresen, T.L.2
  • 33
    • 84906783842 scopus 로고    scopus 로고
    • Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth
    • [in press]
    • Moghimi S.M. Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth. J Control Rel 2014, [in press]. 10.1016/j.jconrel.2014.03.051.
    • (2014) J Control Rel
    • Moghimi, S.M.1
  • 34
    • 84889840938 scopus 로고    scopus 로고
    • Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase
    • Gong L., Cumpian A.M., Catano M.S., Ochoa C.E., la Garza MM De, Lapid D.J., et al. Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase. Mol Cancer 2013, 12:154. [http://www.molecular-cancer.com/content/12/1/154].
    • (2013) Mol Cancer , vol.12 , pp. 154
    • Gong, L.1    Cumpian, A.M.2    Catano, M.S.3    Ochoa, C.E.4    la Garza MM, D.5    Lapid, D.J.6
  • 35
    • 0031135489 scopus 로고    scopus 로고
    • Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils
    • Wirthmueller U., Dewald B., Thelen M., Schafer M.K., Stover C., Whaley K., et al. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol 1997, 158:4444-4451.
    • (1997) J Immunol , vol.158 , pp. 4444-4451
    • Wirthmueller, U.1    Dewald, B.2    Thelen, M.3    Schafer, M.K.4    Stover, C.5    Whaley, K.6
  • 36
    • 33748445698 scopus 로고    scopus 로고
    • Malignancy and hemostasis
    • LippinCott Williams & Wilkins, Philadelphia, R.W. Coleman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldharber (Eds.)
    • Dvorak H.F., Rickles F.R. Malignancy and hemostasis. Hemostasis and Thrombosis: Basic Principles and Clinical Practice 2006, 851-873. LippinCott Williams & Wilkins, Philadelphia. 5th ed. R.W. Coleman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldharber (Eds.).
    • (2006) Hemostasis and Thrombosis: Basic Principles and Clinical Practice , pp. 851-873
    • Dvorak, H.F.1    Rickles, F.R.2
  • 39
    • 84866149234 scopus 로고    scopus 로고
    • Opposing roles of complement component C5a in tumor progression and the tumor microenvironment
    • Gunn L., Ding C., Liu M., Ma Y., Qi C., Cai Y., et al. Opposing roles of complement component C5a in tumor progression and the tumor microenvironment. J Immunol 2012, 189:2985-2993.
    • (2012) J Immunol , vol.189 , pp. 2985-2993
    • Gunn, L.1    Ding, C.2    Liu, M.3    Ma, Y.4    Qi, C.5    Cai, Y.6
  • 40
    • 84855381793 scopus 로고    scopus 로고
    • Immunological variations between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice
    • Sellers R.S., Clifford C.B., Treuting P.M., Brayton C. Immunological variations between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice. Vet Pathol 2012, 39:32-33.
    • (2012) Vet Pathol , vol.39 , pp. 32-33
    • Sellers, R.S.1    Clifford, C.B.2    Treuting, P.M.3    Brayton, C.4
  • 42
    • 2342481765 scopus 로고    scopus 로고
    • Complement activation by apoptotic cells occurs predominantly via IgM and is limited to late apoptotic (secondary necrotic) cells
    • Zwart B., Ciutana C., Rensink I., Manoe R., Hack C.E., Aarden L.A. Complement activation by apoptotic cells occurs predominantly via IgM and is limited to late apoptotic (secondary necrotic) cells. Autoimmunity 2003, 37:95-102.
    • (2003) Autoimmunity , vol.37 , pp. 95-102
    • Zwart, B.1    Ciutana, C.2    Rensink, I.3    Manoe, R.4    Hack, C.E.5    Aarden, L.A.6
  • 43
    • 48249124246 scopus 로고    scopus 로고
    • The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis
    • Kemper C., Mitchell L.M., Zhang L., Hourcade D.E. The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. Proc Natl Acad Sci USA 2008, 105:9023-9028.
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 9023-9028
    • Kemper, C.1    Mitchell, L.M.2    Zhang, L.3    Hourcade, D.E.4
  • 44
    • 84873268296 scopus 로고    scopus 로고
    • The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
    • Maeda H., Nakamura H., Fang J. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev 2013, 65:71-79.
    • (2013) Adv Drug Deliv Rev , vol.65 , pp. 71-79
    • Maeda, H.1    Nakamura, H.2    Fang, J.3
  • 45
    • 79952594233 scopus 로고    scopus 로고
    • Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
    • Diop-Frimpong B., Chauhan V.P., Krane S., Boucher Y., Jain R.K. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci USA 2011, 108:2909-2913.
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 2909-2913
    • Diop-Frimpong, B.1    Chauhan, V.P.2    Krane, S.3    Boucher, Y.4    Jain, R.K.5
  • 46
    • 84887478772 scopus 로고    scopus 로고
    • Combining two strategies to improve perfusion and drug delivery in solid tumors
    • Stylianopoulos T., Jain R.K. Combining two strategies to improve perfusion and drug delivery in solid tumors. Proc Natl Acad Sci USA 2013, 110:18632-18637.
    • (2013) Proc Natl Acad Sci USA , vol.110 , pp. 18632-18637
    • Stylianopoulos, T.1    Jain, R.K.2
  • 47
    • 84866735036 scopus 로고    scopus 로고
    • Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer
    • Kato K., Chin K., Yoshikawa T., Yamaguchi K., Tsuji Y., Esaki T., et al. Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer. Invest New Drug 2012, 30:1621-1627.
    • (2012) Invest New Drug , vol.30 , pp. 1621-1627
    • Kato, K.1    Chin, K.2    Yoshikawa, T.3    Yamaguchi, K.4    Tsuji, Y.5    Esaki, T.6
  • 49
    • 80053997259 scopus 로고    scopus 로고
    • A human memory T cell subset with stem cell-like properties
    • Gattinoni L., Lugli E., Ji Y., Pos Z., Paulos C.M., Quigley M.F., et al. A human memory T cell subset with stem cell-like properties. Nat Med 2011, 17:1290-1297.
    • (2011) Nat Med , vol.17 , pp. 1290-1297
    • Gattinoni, L.1    Lugli, E.2    Ji, Y.3    Pos, Z.4    Paulos, C.M.5    Quigley, M.F.6
  • 50
    • 79251468712 scopus 로고    scopus 로고
    • Mouse models of advanced spontaneous metastasis for experimental therapeutics
    • Francia G., Cruz-Munoz W., Man S., Xu P., Kerbel R.S. Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer 2011, 11:135-141.
    • (2011) Nat Rev Cancer , vol.11 , pp. 135-141
    • Francia, G.1    Cruz-Munoz, W.2    Man, S.3    Xu, P.4    Kerbel, R.S.5
  • 51
    • 80052472086 scopus 로고    scopus 로고
    • Primary human tumor xenografted models ('tumorgrafts') for good management of patients with cancer
    • Decaudin D. Primary human tumor xenografted models ('tumorgrafts') for good management of patients with cancer. Anticancer Drugs 2011, 22:827-831.
    • (2011) Anticancer Drugs , vol.22 , pp. 827-831
    • Decaudin, D.1
  • 52
    • 84860540820 scopus 로고    scopus 로고
    • Human tumor xenografts: the good, the bad and the ugly
    • Morgan R.A. Human tumor xenografts: the good, the bad and the ugly. Mol Ther 2012, 20:882-883.
    • (2012) Mol Ther , vol.20 , pp. 882-883
    • Morgan, R.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.